Eton Pharmaceuticals Inc expected to post a loss of 1 cent a share - Earnings Preview

Eton Pharmaceuticals

08/11/2024 22:42

* Eton Pharmaceuticals Inc  ETON.OQ   ETON.O  is expected
to show
a rise in quarterly revenue when it reports  results on November
12 for the period ending September 30 2024
    * The Deer Park Illinois-based  company is expected to
report a
38.0% increase in revenue to $9.696 million from $7.03 million a
year ago, according to the mean estimate from 2 analysts, based
on LSEG data.
    * ​LSEG's mean analyst estimate for Eton Pharmaceuticals Inc
is
for a loss of 1 cent per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Eton
Pharmaceuticals Inc is $13.00​, above​ its last closing price
of $8.67. ​​​

This summary was machine generated November 8 at 22:42 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)